One in Four Patients in ICU Receive Red Blood Cell Transfusion
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Oct. 16, 2023 -- For patients admitted to intensive care units (ICUs) worldwide, red blood cell (RBC) transfusion is common, with considerable variability across centers, countries, and continents, according to a study published online Oct. 12 in the Journal of the American Medical Association.
Senta Jorinde Raasveld, M.D., from the Amsterdam University Medical Centers, and colleagues examined and described ICU RBC transfusion practices worldwide in an international, prospective cohort study involving 3,643 adults from 233 ICUs in 30 countries across six continents.
The researchers found that 25 percent of the patients received one or more RBC transfusions during their ICU stay, with a median of two units per patient. Across centers, the proportion of patients who received a transfusion varied from 0 to 100 percent, while there was variation from 0 to 80 percent and from 19 to 45 percent across countries and continents, respectively. A total of 1,727 RBC transfusions were administered among patients who received a transfusion; the most common clinical indications were low hemoglobin value, active bleeding, and hemodynamic instability (81.8, 27.7, and 23.5 percent, respectively). Of the events with a stated physiological trigger, hypotension (42.2 percent), tachycardia (27.4 percent), and increased lactate levels (17.8 percent) were the most frequently stated triggers. Of the ICUs, about 84 percent administered transfusions to patients at a median hemoglobin level >7 g/dL.
"A wide range in transfusion occurrence rates was found across centers, countries, and continents," the authors write.
Several authors disclosed ties to the pharmaceutical, medical device, nutrition, and publishing industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
MONDAY, April 8, 2024 -- Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute...
Earlier Receipt of Whole Blood Transfusion Improves Survival
WEDNESDAY, Feb. 7, 2024 -- For patients presenting with severe hemorrhage, receipt of whole blood (WB) transfusion earlier within the first 24 hours of emergency department...
Amid Continuing Shortage, Red Cross Repeats Call for Blood Donors
WEDNESDAY, Jan. 24, 2024 -- As a series of severe winter storms this month has exacerbated the shortage of lifesaving blood, the American Red Cross is again urging people to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.